logo
Burjeel Holdings expands Saudi presence with acquisition of PhysioTrio Physiotherapy Center in Riyadh

Burjeel Holdings expands Saudi presence with acquisition of PhysioTrio Physiotherapy Center in Riyadh

Zawya03-07-2025
Abu Dhabi/Riyadh: Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, has announced the acquisition of a 100% stake in Riyadh's PhysioTrio Physiotherapy Center through its subsidiary, Burjeel Arabia. This strategic move reinforces Burjeel's commitment to expanding its presence in Saudi Arabia and advancing its capabilities in physiotherapy and rehabilitation services.
Established in 2013, PhysioTrio is recognized for its excellence in patient care, operational efficiency, and high patient demand. The center will now become part of Burjeel's PhysioTherabia network, the largest and fastest-growing physiotherapy and wellness network in the Kingdom. This integration further strengthens Burjeel's leadership in the Physiotherapy and rehabilitative care segment in Saudi Arabia.
PhysioTrio is an advanced center with a strong focus on sports rehabilitation. It holds key partnerships, including contracts with the Ministry of Sport, positioning Burjeel to offer cutting-edge sports rehab services tailored to athletes and active individuals across the region.
'Saudi Arabia represents a key pillar in our long-term growth strategy. The acquisition of PhysioTrio expands our footprint in the Kingdom and aligns with our vision to elevate access to high-quality, specialized physiotherapy and wellness services. Through this integration, we are accelerating our efforts to support the Kingdom's healthcare transformation and the goals of Vision 2030,' said Mr. Safeer Ahamed, Co-CEO of Burjeel Holdings.
With the acquisition of the new center, PhysioTherabia now operates 30 facilities across the Kingdom, including Specialist Physiotherapy Center in Mecca and eight others in Riyadh. Renowned for its leadership in sports rehabilitation and wellness, PhysioTherabia will empower the facility to scale its services, streamline operations, and better address the evolving healthcare needs of the local community. Integration into the network will provide access to centralized protocols, AI-driven assessment tools, and standardized training programs, ensuring consistent, high-quality care. Additionally, PhysioTherabia plans to forge new partnerships and invest in innovations tailored to the region.
'This expansive network provides a solid foundation to elevate the services of the newly integrated facility, enabling the delivery of advanced rehabilitation programs and strengthening access to high-quality physiotherapy care across the region,' said Abdulmohsen Al Ashry, Regional CEO – KSA at Burjeel Holdings.
This expansion builds on Burjeel's recent initiatives in the Kingdom, including the integration of Aspris Healthcare, a mental health platform in Riyadh, through its joint venture Alkalma. The Group is also advancing its presence in day surgery, digital health, and complex care delivery to contribute meaningfully to Saudi Arabia's healthcare ambitions.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Novo Nordisk partners with Saudi Heart Association to improve cardiovascular health in Saudi Arabia
Novo Nordisk partners with Saudi Heart Association to improve cardiovascular health in Saudi Arabia

Zawya

time4 hours ago

  • Zawya

Novo Nordisk partners with Saudi Heart Association to improve cardiovascular health in Saudi Arabia

Riyadh, Saudi Arabia, - Novo Nordisk, a leading global healthcare company, is excited to announce a new Memorandum of Understanding with the Saudi Heart Association (SHA), aimed at improving cardiovascular care throughout Saudi Arabia. This strategic partnership will engage clinicians in a series of educational and research initiatives designed to provide optimal, multidisciplinary care for patients across the Kingdom. The collaboration seeks to enhance patient outcomes nationwide by equipping healthcare professionals with vital knowledge and resources. This effort aligns with the objectives of Saudi Vision 2030, which aims to address the clinical and economic challenges posed by cardiovascular disease. Cardiovascular diseases present a significant public health challenge in Saudi Arabia, with rising rates of related major risk factors, including obesity, diabetes, and inflammation. Besides traditional risk factors, systemic low-grade inflammation is nowadays recognized as a driving force of atherosclerotic disease progression and plaque destabilization. In 2016, approximately 201,300 Saudi nationals were affected by cardiovascular diseases, accounting for over 45% of fatalities in the country. This partnership is dedicated to tackling these pressing issues by fostering effective management strategies and enhancing clinical practices. Novo Nordisk and SHA are committed to establishing a comprehensive framework for early intervention, significantly improving the quality of care provided to patients. The partnership will leverage diverse communication channels to reach healthcare providers, delivering thorough education on the latest advancements in cardiovascular care. "At Novo Nordisk, we understand the critical importance of collaboration in advancing cardio care," said Melvin D'Souza, General Manager at Novo Nordisk Saudi Arabia. "Our partnership with the Saudi Heart Association marks a proactive step toward enhancing cardiovascular health practices and ultimately improving patient outcomes across the Kingdom." "We are thrilled about this collaboration with Novo Nordisk and its potential impact," stated Dr. Waleed AlHabeeb, President of the Saudi Heart Association. "By working together, we can empower healthcare providers with the essential knowledge and skills to effectively manage cardiovascular patients, contributing to a healthier future for our communities." About Novo Nordisk Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 76,300 people in 80 countries and markets its products in around 170 countries. For more information, visit Facebook, Instagram, X, LinkedIn and YouTube. About Saudi Heart Association Saudi Heart Association (SHA) is a professional organization dedicated to advancing the field of cardiology in Saudi Arabia. Founded in 1987, it serves as a scientific reference for local bodies and works to disseminate knowledge and best practices in cardiovascular health. SHA is involved in various activities, including research, training, and public awareness campaigns, and hosts an annual Contacts for further information Media: Julie Andersen Public Affairs Specialist LJRT@ Islam Tawfik Sr. Medical Manager IZQT@ References Tash, Adel Abdulkader and Al-Bawardy, Rasha Fahad (2023) "Cardiovascular Disease in Saudi Arabia: facts and the way forward," Journal of the Saudi Heart Association: Vol. 35: Iss. 2, Article 6. Available at:

Polio vaccination drive targets 1.3m children in government-controlled Yemen
Polio vaccination drive targets 1.3m children in government-controlled Yemen

The National

time11 hours ago

  • The National

Polio vaccination drive targets 1.3m children in government-controlled Yemen

The World Health Organisation has launched a three-day polio vaccination campaign in Yemen, targeting 1.3 million children across 12 provinces under government control. Yemen is at high risk for poliovirus outbreaks due to the civil war, which has weakened the healthcare and water hygiene systems, the WHO has said. 'With poliovirus continuing to circulate and cases confirmed in 2025, these [vaccination] campaigns are essential to interrupt transmission and protect every child from the debilitating effects of polio,' WHO Representative in Yemen Dr Ferima Coulibaly-Zerbo said. More than 280 cases of poliovirus have been recorded in Yemen since 2021, across 19 of the country's 22 provinces. Nearly all the cases have involved children under five years old. The campaign is being run by the WHO, led by the Ministry of Health, with support from Unicef – the UN agency for children - and the Global Polio Eradication Initiative. Nearly 7,000 vaccination teams, including 6,000 going door-to-door and 800 others at health care facilities, are inoculating children. 'The campaign is an important and urgent step to protect children from being paralysed by the poliovirus,' said Unicef's Representative to Yemen, Peter Hawkins. 'With confirmed cases of polio among Yemeni children, an imminent threat persists, especially for every unvaccinated child. But through vaccination we can keep our children safe.' Yemen was polio-free for decades until 2020, but national polio immunisation coverage dropped from 58 per cent in 2022 to 46 per cent in 2023, Unicef said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store